Skip to Content
Merck

20811

ORBO 80 Isocyanate Filter

with cassettes: no, filter O.D. 37 mm, pkg of 25 ea

Synonym(s):

ORBO 80 Coated Filter

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

UNSPSC Code:
41104900
NACRES:
NB.21
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

material

glass fiber filter

agency

ASTM® D5836, OSHA 5002

product line

ORBO

packaging

pkg of 25 ea

manufacturer/tradename

ORBO 80

technique(s)

active air sampling: suitable

filter O.D.

37 mm

matrix active group

1,2-PP, 1-(2-pyridyl)piperazine

application(s)

air monitoring
environmental
industrial hygiene

compatibility

for analyte group isocyanate

storage temp.

2-8°C

General description

ORBO 80 Coated 1,2-PP Filter is a 1-(2-pyridyl) piperazine coated glass fiber filter best suited for sampling diisocyanates in the air (OSHA Methods 42 and 47).

Legal Information

ASTM is a registered trademark of American Society for Testing and Materials
ORBO is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A Orbo et al.
Gynecologic oncology, 95(1), 82-88 (2004-09-24)
The purpose of the current study was to characterize the role of PTEN in malignant transformation and to evaluate the significance of mutated PTEN exons as prognostic markers in the carcinogenesis of endometrial hyperplasia. A comparison of PTEN mutations as
J P Baak et al.
The American journal of surgical pathology, 25(7), 930-935 (2001-06-23)
Prospective multicenter evaluation of the WHO classification and the morphometric D-score to predict endometrial hyperplasia cancer progression. In 132 endometrial hyperplasias WHO classification was performed by two experienced gynecologic pathologists. The D-score was assessed blindly by technicians in a routine
A Ørbo et al.
BJOG : an international journal of obstetrics and gynaecology, 123(9), 1512-1519 (2015-12-03)
To investigate relapse rates after the successful treatment of patients with non-atypical endometrial hyperplasia who were randomised to either a levonorgestrel-impregnated intrauterine system (LNG-IUS; Mirena(®) ) or two regimens of oral medroxyprogesterone acetate (MPA) after primary histological response. A multicentre
A Orbo et al.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 22(2), 141-148 (2003-03-22)
Derangements in the tumor suppressor gene PTEN and the mismatch-repair genes, hMLH1, hMSH2, and hMSH6, have an important role in endometrial carcinogenesis. The purpose of this study was to assess immunohistochemically the pattern of protein expression for these genes in
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service